← FDA DRUG APPROVALS

FDA ANDA · ANDA203167

CLONIDINE

Sponsor: XGEN PHARMS

APPLICATION
ANDA203167
TYPE
ANDA
ORIGINAL APPROVAL
2013-10-29
LATEST ACTION
2013-10-29
ROUTE
EPIDURAL, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

CLONIDINE HYDROCHLORIDEPrescription
CLONIDINE HYDROCHLORIDE 5MG/10ML (0.5MG/ML) · INJECTABLE · INJECTION
CLONIDINE HYDROCHLORIDEPrescription
CLONIDINE HYDROCHLORIDE 1MG/10ML (0.1MG/ML) · INJECTABLE · INJECTION

Approval history

2013-10-29UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →